AF
AMPE

Amalgamated Financial’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Amalgamated Financial’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$15K Buy
+106
New +$15.5K ﹤0.01% 2824

Other funds holding AMPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

Amalgamated Financial's AMPE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Ampio Pharmaceuticals Inc. (AMPE) in Q1 2022: 106 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2824 among its holdings.

128 funds tracked by Wall St. Rank hold AMPE as of Q1 2022.

  • Amalgamated Financial held 106 shares of Ampio Pharmaceuticals Inc. worth $15K as of Q1 2022.
  • Ampio Pharmaceuticals Inc. was a new Amalgamated Financial position in Q1 2022.
  • Ampio Pharmaceuticals Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2824 holding.
  • 128 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.